Aurinia Pharmaceuticals Inc.
AUPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,515,820 | $1,176,627 | $1,116,893 | $1,276,767 |
| - Cash | $73,189 | $53,002 | $66,428 | $83,433 |
| + Debt | $78,212 | $81,830 | $77,910 | $79,369 |
| Enterprise Value | $1,520,843 | $1,205,455 | $1,128,375 | $1,272,703 |
| Revenue | $73,468 | $70,008 | $62,465 | $59,867 |
| % Growth | 4.9% | 12.1% | 4.3% | – |
| Gross Profit | $64,964 | $62,893 | $53,891 | $54,315 |
| % Margin | 88.4% | 89.8% | 86.3% | 90.7% |
| EBITDA | $36,827 | $28,137 | $30,272 | $7,181 |
| % Margin | 50.1% | 40.2% | 48.5% | 12% |
| Net Income | $31,551 | $21,513 | $23,344 | $1,429 |
| % Margin | 42.9% | 30.7% | 37.4% | 2.4% |
| EPS Diluted | 0.23 | 0.15 | 0.16 | 0.01 |
| % Growth | 53.3% | -6.3% | 1,500% | – |
| Operating Cash Flow | $44,449 | $44,241 | $1,300 | $30,114 |
| Capital Expenditures | -$65 | -$98 | -$17 | -$56 |
| Free Cash Flow | $44,384 | $44,143 | $1,283 | $30,058 |